Ardent Health’s (ARDT) Outperform Rating Reiterated at Leerink Partners

by · The Cerbat Gem

Leerink Partners reaffirmed their outperform rating on shares of Ardent Health (NYSE:ARDT – Free Report) in a research report sent to investors on Friday morning,Benzinga reports. Leerink Partners currently has a $14.00 target price on the stock.

Several other equities research analysts have also recently weighed in on ARDT. Weiss Ratings cut Ardent Health from a “sell (d+)” rating to a “sell (d)” rating in a research report on Tuesday, August 11th. Wall Street Zen downgraded shares of Ardent Health from a “buy” rating to a “hold” rating in a report on Sunday, July 12th. Guggenheim raised their price target on shares of Ardent Health from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Zacks Research upgraded shares of Ardent Health from a “strong sell” rating to a “hold” rating in a report on Monday, September 7th. Finally, Royal Bank Of Canada boosted their price objective on shares of Ardent Health from $12.00 to $13.00 and gave the stock an “outperform” rating in a report on Monday, August 10th. Seven research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, Ardent Health presently has an average rating of “Hold” and an average target price of $12.95.

View Our Latest Analysis on ARDT

Ardent Health Stock Down 0.3%

Ardent Health stock opened at $10.44 on Friday. The firm has a market cap of $1.47 billion, a price-to-earnings ratio of 18.99, a P/E/G ratio of 2.97 and a beta of 0.71. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.10 and a quick ratio of 1.99. Ardent Health has a fifty-two week low of $7.71 and a fifty-two week high of $15.48. The firm has a fifty day moving average price of $10.80 and a two-hundred day moving average price of $9.90.

Ardent Health (NYSE:ARDT – Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.06). Ardent Health had a net margin of 1.22% and a return on equity of 10.35%. The business had revenue of $1.62 billion during the quarter, compared to analyst estimates of $1.59 billion. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. As a group, analysts forecast that Ardent Health will post 0.96 earnings per share for the current year.

Institutional Trading of Ardent Health

Several institutional investors have recently bought and sold shares of the stock. WINTON GROUP Ltd acquired a new position in Ardent Health during the second quarter worth $124,000. Integrated Wealth Concepts LLC acquired a new stake in shares of Ardent Health in the 2nd quarter valued at $57,000. Allworth Financial LP grew its holdings in shares of Ardent Health by 131.3% in the 2nd quarter. Allworth Financial LP now owns 2,863 shares of the company’s stock worth $28,000 after purchasing an additional 1,625 shares during the last quarter. Corient Private Wealth LP bought a new stake in shares of Ardent Health in the 2nd quarter worth about $159,000. Finally, AXQ Capital LP increased its position in shares of Ardent Health by 69.3% during the 2nd quarter. AXQ Capital LP now owns 25,045 shares of the company’s stock worth $246,000 after purchasing an additional 10,249 shares in the last quarter.

About Ardent Health

(Get Free Report)

Ardent Health is a U.S. healthcare provider that owns and operates hospitals, outpatient facilities and other healthcare services. The company delivers a broad range of medical care, including emergency services, inpatient and outpatient treatment, primary care, specialty care, surgical services, behavioral health and urgent care.

Headquartered in Nashville, Tennessee, Ardent serves communities through a network of hospitals and healthcare sites in several states, including Texas, Oklahoma, New Mexico and Kansas.

Read More